These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27390282)

  • 1. Beta-blockers in COPD: time for reappraisal.
    Lipworth B; Wedzicha J; Devereux G; Vestbo J; Dransfield MT
    Eur Respir J; 2016 Sep; 48(3):880-8. PubMed ID: 27390282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
    Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
    Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
    Salpeter SS; Ormiston T; Salpeter E; Poole P; Cates C
    Cochrane Database Syst Rev; 2002; (2):CD003566. PubMed ID: 12076486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
    Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
    Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.
    Salpeter SR; Ormiston TM; Salpeter EE; Poole PJ; Cates CJ
    Respir Med; 2003 Oct; 97(10):1094-101. PubMed ID: 14561016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.
    Short PM; Lipworth SI; Elder DH; Schembri S; Lipworth BJ
    BMJ; 2011 May; 342():d2549. PubMed ID: 21558357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly.
    Leitao Filho FS; Choi L; Sin DD
    Curr Opin Pulm Med; 2021 Mar; 27(2):125-131. PubMed ID: 33332878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.
    Petta V; Perlikos F; Loukides S; Bakakos P; Chalkias A; Iacovidou N; Xanthos T; Tsekoura D; Hillas G
    Heart Fail Rev; 2017 Nov; 22(6):753-763. PubMed ID: 28840400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioselective beta-blockers for reversible airway disease.
    Salpeter S; Ormiston T; Salpeter E
    Cochrane Database Syst Rev; 2002; (1):CD002992. PubMed ID: 11869646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT.
    Dransfield MT; McAllister DA; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Gallot N; Martinez FJ; Scanlon PD; Yates J; Vestbo J; Newby DE;
    Ann Am Thorac Soc; 2018 May; 15(5):608-614. PubMed ID: 29406772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
    Salpeter S; Ormiston T; Salpeter E
    Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD003566. PubMed ID: 16235327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
    Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
    BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioselective beta-blockers for reversible airway disease.
    Salpeter S; Ormiston T; Salpeter E
    Cochrane Database Syst Rev; 2002; (4):CD002992. PubMed ID: 12519582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
    Mtisi TF; Frishman WH
    Cardiol Rev; 2020; 28(1):20-25. PubMed ID: 31804289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Blockers, heart disease and COPD: current controversies and uncertainties.
    Baker JG; Wilcox RG
    Thorax; 2017 Mar; 72(3):271-276. PubMed ID: 27927840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Mersfelder TL; Shiltz DL
    Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of cardioselective β-blockers in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized, placebo-controlled, blinded trials.
    Ni Y; Shi G; Wan H
    J Int Med Res; 2012; 40(6):2051-65. PubMed ID: 23321161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise.
    Chang CL; Mills GD; McLachlan JD; Karalus NC; Hancox RJ
    Intern Med J; 2010 Mar; 40(3):193-200. PubMed ID: 19383058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
    Glaab T; Weiss T
    Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.